M. Jhaveri

发表

Performance of Electronic Diaries in Diabetes Clinical Trials Measured through Overall Satisfaction of Site Coordinators

M. Jhaveri, Elizabeth Lee, 2007, Journal of diabetes science and technology.

Table 2 On-Campus Injury / Illness Among Minors & Students

M. Jhaveri, D. Shendell, K. Jennifer, 2011 .

Incident Surveillance in New Jersey Career and Technical Education Programs, 1999 to 2008

M. Jhaveri, D. Shendell, S. Kelly, 2010, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter

M. Jhaveri, Jay Lin, A. Koren, 2014, Advances in Therapy.

Cost and resource utilization comparisons of second-generation antihistamines vs. montelukast for allergic rhinitis treatment.

M. Jhaveri, M. Kaliner, J. Hay, 2009, Allergy and asthma proceedings.

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA

M. Jhaveri, C. Asche, C. McAdam-Marx, 2009, Osteoporosis International.

Hospital Readmissions in US Atrial Fibrillation Patients: Occurrence and Costs

A. Amin, M. Jhaveri, Jay Lin, 2013, American journal of therapeutics.

Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy.

J. Alpert, M. Jhaveri, E. Wu, 2013, International journal of cardiology.

Predictors of progression of recently diagnosed atrial fibrillation in REgistry on Cardiac Rhythm DisORDers Assessing the Control of Atrial Fibrillation (RecordAF)-United States cohort.

P. Kowey, M. Jhaveri, E. Prystowsky, 2013, The American journal of cardiology.

Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation.

M. Turakhia, M. Solomon, M. Jhaveri, 2013, Journal of comparative effectiveness research.

One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.

M. Jhaveri, Jay Lin, Michael H. Kim, 2011, Clinical therapeutics.

Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation.

M. Turakhia, M. Solomon, M. Jhaveri, 2013, American heart journal.

Estimation of Potential Cost Savings Associated With Reduced Rates of Cardiovascular Hospitalization Among Atrial Fibrillation/Flutter Patients Treated With Dronedarone in the ATHENA Trial

M. Jhaveri, M. Reynolds, Jay Lin, 2014, American journal of therapeutics.

Cost-effectiveness of dronedarone and standard of care compared with standard of care alone: US results of an ATHENA lifetime model

M. Jhaveri, J. Nilsson, M. Reynolds, 2013, ClinicoEconomics and outcomes research : CEOR.

Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors

A. Amin, M. Jhaveri, Jay Lin, 2012, Journal of medical economics.

Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis.

M. Jhaveri, Pengxiang Li, J. Doshi, 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States

M. Jhaveri, A. Fu, 2012, Journal of medical economics.

Original article Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States

M. Jhaveri, A. Fu, 2012 .

Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks

M. Jhaveri, Deren Huang, R. Naismith, 2018, Patient preference and adherence.

All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States

M. Jhaveri, Aaron E Miller, C. Asche, 2010, Journal of managed care pharmacy : JMCP.

Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.

M. Jhaveri, D. Ontaneda, J. Nicholas, 2019, Multiple sclerosis and related disorders.

Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database.

M. Jhaveri, J. Foody, L. Lamerato, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms.

M. Jhaveri, B. Nightengale, M. Goodman, 2008, American health & drug benefits.

Development of an Algorithm to Identify Multiple Sclerosis (MS) Disease Severity Based on Healthcare Costs in a US Administrative Claims Database (P2.052)

M. Jhaveri, D. Ontaneda, J. Nicholas, 2017 .

Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors

A. Amin, M. Jhaveri, Jay Lin, 2011, Advances in therapy.

Patient and physician preferences for multiple sclerosis treatments in Germany: A discrete-choice experiment study

T. Schenk, M. Jhaveri, C. Poulos, 2020, Multiple sclerosis journal - experimental, translational and clinical.